Welcome to LookChem.com Sign In|Join Free

CAS

  • or

128455-63-0 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 128455-63-0 Structure
  • Basic information

    1. Product Name: 5-CHLORO-1-METHYL-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBOXYLIC ACID
    2. Synonyms: 5-Chloro-1-methyl-3-(trifluoromethyl)-1H-pyrazole-4-carboxylicacid97%;5-Chloro-1-methyl-3-(trifluoromethyl);BUTTPARK 99\18-36;5-CHLORO-1-METHYL-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBOXYLIC ACID;RARECHEM AL BO 1764;4-Carboxy-5-chloro-1-methyl-3-(trifluoromethyl)-1H-pyrazole
    3. CAS NO:128455-63-0
    4. Molecular Formula: C6H4ClF3N2O2
    5. Molecular Weight: 228.56
    6. EINECS: 1312995-182-4
    7. Product Categories: Heterocyclic Building Blocks;New Products for Chemical Synthesis;Pyrazoles;Carboxylic Acids;Pyrazoles & Triazoles;Carboxylic Acids;Pyrazoles & Triazoles;Building Blocks;Pyrazole;C6;Chemical Synthesis
    8. Mol File: 128455-63-0.mol
    9. Article Data: 9
  • Chemical Properties

    1. Melting Point: 201 °C
    2. Boiling Point: 284.4 °C at 760 mmHg
    3. Flash Point: 125.8 °C
    4. Appearance: /
    5. Density: 1.71 g/cm3
    6. Vapor Pressure: 0.0014mmHg at 25°C
    7. Refractive Index: N/A
    8. Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
    9. Solubility: N/A
    10. PKA: 1.77±0.50(Predicted)
    11. CAS DataBase Reference: 5-CHLORO-1-METHYL-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBOXYLIC ACID(CAS DataBase Reference)
    12. NIST Chemistry Reference: 5-CHLORO-1-METHYL-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBOXYLIC ACID(128455-63-0)
    13. EPA Substance Registry System: 5-CHLORO-1-METHYL-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBOXYLIC ACID(128455-63-0)
  • Safety Data

    1. Hazard Codes: Xi,Xn
    2. Statements: 20/21/22-36/37/38
    3. Safety Statements: 26
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: IRRITANT
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 128455-63-0(Hazardous Substances Data)

128455-63-0 Usage

Description

5-CHLORO-1-METHYL-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBOXYLIC ACID is a pyrazole derivative with the molecular formula C7H5ClF3N3O2. It features a chloro and a methyl group at specific positions on the pyrazole ring, along with a carboxylic acid functional group. 5-CHLORO-1-METHYL-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBOXYLIC ACID is utilized in various research and industrial applications, particularly as a building block in the synthesis of pharmaceuticals and agrochemicals. Its trifluoromethyl group enhances the bioavailability and metabolic stability of drug candidates, making it a valuable component in medicinal chemistry.

Uses

Used in Pharmaceutical Synthesis:
5-CHLORO-1-METHYL-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBOXYLIC ACID is used as a building block for the synthesis of pharmaceuticals, contributing to the development of new drugs with improved bioavailability and metabolic stability due to the presence of the trifluoromethyl group.
Used in Agrochemical Synthesis:
In the agrochemical industry, 5-CHLORO-1-METHYL-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBOXYLIC ACID serves as a key component in the creation of agrochemicals, potentially enhancing the effectiveness and stability of these compounds for agricultural applications.
Used as a Reagent in Organic Synthesis:
5-CHLORO-1-METHYL-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-4-CARBOXYLIC ACID is utilized as a reagent in organic synthesis to introduce the pyrazole-4-carboxylic acid motif into molecules, allowing for the creation of a variety of chemical entities with specific properties and applications.

Check Digit Verification of cas no

The CAS Registry Mumber 128455-63-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,8,4,5 and 5 respectively; the second part has 2 digits, 6 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 128455-63:
(8*1)+(7*2)+(6*8)+(5*4)+(4*5)+(3*5)+(2*6)+(1*3)=140
140 % 10 = 0
So 128455-63-0 is a valid CAS Registry Number.
InChI:InChI=1/C6H4ClF3N2O2/c1-12-4(7)2(5(13)14)3(11-12)6(8,9)10/h1H3,(H,13,14)/p-1

128455-63-0 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Aldrich

  • (L511013)  5-Chloro-1-methyl-3-(trifluoromethyl)-1H-pyrazole-4-carboxylic acid  AldrichCPR

  • 128455-63-0

  • L511013-1G

  • 1,290.51CNY

  • Detail

128455-63-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 5-Chloro-1-methyl-3-(trifluoromethyl)-1H-pyrazole-4-carboxylic acid

1.2 Other means of identification

Product number -
Other names 5-chloro-1-methyl-3-(trifluoromethyl)pyrazole-4-carboxylic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:128455-63-0 SDS

128455-63-0Relevant articles and documents

Synthesis of novel EP4 antagonists and their use in cancer and inflammation

-

Paragraph 0275; 0280-0285; 1144; 1149-1154, (2021/09/08)

The present invention relates to a compound capable of effectively antagonizing EP4, which is a compound represented by formula I, or a tautomer, a stereoisomer, a hydrate, a solvate, a pharmaceutically-acceptable salt or a prodrug of the compound represented by formula I. R1 is selected from -CH3, -CHF2, and -CF3; R2 is selected from C2-C6 alkyl, C3-C6 cycloalkyl, halogenated C2-C6 alkyl, and halogenated C3-C6 cycloalkyl; R3 is selected from hydrogen, halogen, C1-C2 alkyl, and fluorinated C1-C2 alkyl; R4 is selected from hydrogen, halogen, C1-C6 alkyl, C1-C6 alkoxy, halogenated C1-C6 alkyl, and halogenated C1-C6 alkoxy.

Design, synthesis, antifungal activity and 3D-QSAR study of novel pyrazole carboxamide and niacinamide derivatives containing benzimidazole moiety

Si, Wei-Jie,Wang, Xiao-Bin,Chen, Min,Wang, Meng-Qi,Lu, Ai-Min,Yang, Chun-Long

, p. 3000 - 3010 (2019/02/17)

A series of novel pyrazole carboxamide and niacinamide derivatives containing a benzimidazole moiety were designed and synthesized as antifungal candidate agents. All target compounds were characterized by FTIR, 1H NMR, 13C NMR, HRMS and elemental analysis techniques. The structure of compound T1 was further confirmed by single crystal X-ray diffraction analysis. The antifungal activities of the target compounds were evaluated in vitro against four phytopathogenic fungi (namely Botrytis cinerea, Rhizoctonia solani, Fusarium graminearum and Alternaria solani) by the mycelium growth inhibition method. The bioassay results indicated that some of the compounds exhibited good antifungal activity against B. cinerea at 100 μg ML?1 compared to other three fungi. In order to better explore the structure-activity relationship (SAR), the EC50 values of target compounds against B. cinerea were measured and assessed. Subsequently, a 3D quantitative structure-activity relationship (3D-QSAR) study was carried out using the comparative molecular field analysis (CoMFA) technique based on the inhibitory activities of tested compounds against B. cinerea. Molecular modelling results revealed fine predictive ability with cross-validated q2 and non-cross-validated r2 values of 0.578 and 0.850, respectively.

Synthesis and antiviral activity of novel pyrazole amides containing α-aminophosphonate moiety

Wu, Lintao,Song, Baoan,Bhadury, Pinaki S.,Yang, Song,Hu, Deyu,Jin, Linhong

, p. 389 - 396 (2011/06/20)

A series of novel pyrazole amides J1-J15 containing an α-aminophosphonate moiety were synthesized and subsequently characterized by spectral (IR, 1H-, 13C-, 31P-, and 19F-NMR) data and elemental analysis. The racemic sample of J1 was further separated into its enantiomers under normal-phase condition on two immobilized polysaccharide-based chiral stationary phases (Chiralpak IA and Chiralpak IC). The synthesized compounds revealed certain degree of antiviral activity in the bioassay. The title compounds (J 3, J10, and J12) showed some curative activities (39.9%, 41.8%, 50.1%, respectively) against tobacco mosaic virus at 0.5 mg/mL.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 128455-63-0